Enterprise HL7 / FHIR Terminology Engine

Universal Clinical Codes & Terminology Search

Search, verify, and inspect standardized LOINC, SNOMED CT, ICD-10-CM, RxNorm, and CPT clinical codes with native HL7 FHIR R4 resource mappings.

/
Showing 20 of 80174 codes
Per page:
Need to map or validate codes in bulk?
Cross-reference up to 1,000 ICD-10, LOINC, and CPT records simultaneously in memory with our free utility.
Open Bulk Crosswalk Tool →
Code Value Display Description Code System & OID FHIR Resource Category Status Actions
XW043CA
Introduction of Zanidatamab Antineoplastic into Central Vein Percutaneous Approach New Technology Group 10
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW043E5
Introduction of Remdesivir Anti-infective into Central Vein Percutaneous Approach New Technology Group 5
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW043F3
Introduction of Other New Technology Therapeutic Substance into Central Vein Percutaneous Approach New Technology Group 3
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW043F5
Introduction of Other New Technology Therapeutic Substance into Central Vein Percutaneous Approach New Technology Group 5
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW043FA
Introduction of Non-Chimeric Antigen Receptor T-cell Immune Effector Cell Therapy into Central Vein Percutaneous Approach New Technology Group 10
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW043FB
Introduction of Valoctocogene Roxaparvovec-rvox into Central Vein Percutaneous Approach New Technology Group 11
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW043G5
Introduction of Sarilumab into Central Vein Percutaneous Approach New Technology Group 5
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW043G6
Introduction of REGN-COV2 Monoclonal Antibody into Central Vein Percutaneous Approach New Technology Group 6
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW043G7
Introduction of Allogeneic Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Central Vein Percutaneous Approach New Technology Group 7
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW043H5
Introduction of Tocilizumab into Central Vein Percutaneous Approach New Technology Group 5
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW043H6
Introduction of Other New Technology Monoclonal Antibody into Central Vein Percutaneous Approach New Technology Group 6
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW043H7
Introduction of Axicabtagene Ciloleucel Immunotherapy into Central Vein Percutaneous Approach New Technology Group 7
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW043J7
Introduction of Tisagenlecleucel Immunotherapy into Central Vein Percutaneous Approach New Technology Group 7
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW043K7
Introduction of Idecabtagene Vicleucel Immunotherapy into Central Vein Percutaneous Approach New Technology Group 7
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW043K9
Introduction of Sulbactam-Durlobactam into Central Vein Percutaneous Approach New Technology Group 9
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW043L6
Introduction of CD24Fc Immunomodulator into Central Vein Percutaneous Approach New Technology Group 6
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW043L7
Introduction of Lifileucel Immunotherapy into Central Vein Percutaneous Approach New Technology Group 7
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW043M7
Introduction of Brexucabtagene Autoleucel Immunotherapy into Central Vein Percutaneous Approach New Technology Group 7
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW043MA
Introduction of Emapalumab-lzsg Anti-IFNy Monoclonal Antibody into Central Vein Percutaneous Approach New Technology Group 10
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW043N7
Introduction of Lisocabtagene Maraleucel Immunotherapy into Central Vein Percutaneous Approach New Technology Group 7
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
Page 4003 of 4009
Healthcare Terminology & FHIR R4 Interoperability
Standardized coding guidelines governed by CodesForMD

In HL7 FHIR R4, discrete clinical findings and laboratory measurements are encapsulated inside Observation resources. Diagnostic terms and problem list entries are represented within Condition resources, while surgical and therapeutic acts map to Procedure. CodesForMD adheres to official US Core and International FHIR Implementation Guides.

An OID is an internationally standardized dotted-decimal identifier (e.g. 2.16.840.1.113883.6.1 for LOINC) registered with HL7 and ISO. OIDs ensure unambiguous identification of terminology authorities when exchanging clinical messages across heterogeneous EHR, LIS, and PACS systems.

Yes. You can visit our platform's administrative ingestion and export engine or contact our team to obtain batch files of standardized codes.
Copied to clipboard!